1063P Differential tumor responses are a poor prognostic factor in patients receiving immune checkpoint inhibitors
| Autor: | Tozzi, C. 1, Ligero, M. 1, Antolin, A. 1, Atlagich, L.M. 1, Staikoglou, N. 1, Bernatowicz, K. 1, Vieito Villar, M. 2, Alonso, G. 3, Galvao, V. 3, Braña, I. 3, Oberoi, A. 3, Saavedra Santa Gadea, O. 3, Muñoz Couselo, E. 3, Garralda, E. 3, Perez Lopez, R. 1 |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S642-S643 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|